Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 7
Submit an article Journal homepage
195
Views
1
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Torsade de pointe due to QT prolongation following erythromycin administration in a preterm infant

Caroline Fobea Department of Neonatology, Cliniques Universitaires Saint Luc, Bruxelles, Belgium
,
Benedicte Van Grambezena Department of Neonatology, Cliniques Universitaires Saint Luc, Bruxelles, Belgium
,
Stéphane Moniotteb Department of Pediatric Cardiology, Cliniques Universitaires Saint Luc, Bruxelles, Belgium
,
Christophe Vob Department of Pediatric Cardiology, Cliniques Universitaires Saint Luc, Bruxelles, Belgium
,
Anneliese Dussartc Department of Neonatology, CHU, Tivoli, Belgium
,
Olivier Danhaivea Department of Neonatology, Cliniques Universitaires Saint Luc, Bruxelles, Belgium
&
Fiammetta Piersigillia Department of Neonatology, Cliniques Universitaires Saint Luc, Bruxelles, BelgiumCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6581-2822
ORCID Icon show all
Pages 597-601 | Received 13 May 2021, Accepted 08 Aug 2021, Published online: 23 Aug 2021

References

  • McGovern M, Giannoni E, Kuester H, et al. Challenges in developing a consensus definition of neonatal sepsis. Pediatr Res. 2020;88(1):14–26.
  • Randis TM, Rice MM, Myatt L, et al. Incidence of early-onset sepsis in infants born to women with clinical chorioamnionitis. J Perinat Med. 2018;46(8):926–933.
  • Villamor-Martinez E, Álvarez-Fuente M, Ghazi AMT, et al. Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants: a systematic review, meta-analysis, and metaregression. JAMA Netw Open. 2019;2(11):e1914611.
  • Villamor-Martinez E, Fumagalli M, Mohammed Rahim O, et al. Corrigendum: chorioamnionitis is a risk factor for intraventricular hemorrhage in preterm infants: a systematic review and meta-analysis. Front Physiol. 2018;10:102.
  • Romero-Guzman GJ, Lopez-Munoz F. Prevalencia y factores de riesgo de leucomalacia periventricular en recien nacidos prematuros. Revision sistematica [Prevalence and risk factors for periventricular leukomalacia in preterm infants. A systematic review]. Rev Neurol. 2017;65(2):57–62.
  • Pappas A, Kendrick DE, Shankaran S, et al. Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr. 2014;168(2):137–147.
  • Polin RA, Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129(5):1006–1015.
  • Resch B, Gutmann C, Reiterer F, et al. Neonatal Ureaplasma urealyticum colonization increases pulmonary and cerebral morbidity despite treatment with macrolide antibiotics. Infection. 2016;44(3):323–327.
  • Tantengco OAG, Yanagihara I. Current understanding and treatment of intra-amniotic infection with ureaplasma spp. J Obstet Gynaecol Res. 2019;45(9):1796–1808.
  • Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin no. 188: prelabor rupture of membranes. Obstet Gynecol. 2018;131(1):e1–e14.
  • Glaser K, Gradzka-Luczewska A, Szymankiewicz-Breborowicz M, et al. Perinatal ureaplasma exposure is associated with increased risk of late onset sepsis and imbalanced inflammation in preterm infants and may add to lung injury. Front Cell Infect Microbiol. 2019;9:68.
  • Viscardi RM, Kallapur SG. Role of ureaplasma respiratory tract colonization in bronchopulmonary dysplasia pathogenesis: current concepts and update. Clin Perinatol. 2015;42(4):719–738.
  • Viscardi RM, Terrin ML, Magder LS, et al. Randomised trial of azithromycin to eradicate ureaplasma in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2020;105(6):615–622.
  • Nair V, Loganathan P, Soraisham AS. Azithromycin and other macrolides for prevention of bronchopulmonary dysplasia: a systematic review and meta-analysis. Neonatology. 2014;106(4):337–347.
  • Nogami K, Nishikubo T, Minowa H, et al. Intravenous low-dose erythromycin administration for infants with feeding intolerance. Pediatr Int. 2001;43(6):605–610.
  • Ericson JE, Arnold C, Cheeseman J, et al. Use and safety of erythromycin and metoclopramide in hospitalized infants. J Pediatr Gastroenterol Nutr. 2015;61(3):334–339.
  • Smith C, Egunsola O, Choonara I, et al. Use and safety of azithromycin in neonates: a systematic review. BMJ Open. 2015;5(12):e008194.
  • Mei J, Harter K, Danhaive O, et al. Implications of intrapartum azithromycin on neonatal microbiota. Lancet Infect Dis. 2017;17(3):253–254.
  • Auriti C, Piersigilli F, Bersani I, et al. Staphylococcal meningitis therapy with linezolid in a young infant: efficacy, CSF levels and side effects. Ital J Pediatr. 2020;46(1):90.
  • Mason JW. Antimicrobials and QT prolongation. J Antimicrob Chemother. 2017;72(5):1272–1274.
  • Giudicessi JR, Ackerman MJ, Camilleri M. Cardiovascular safety of prokinetic agents: a focus on drug-induced arrhythmias. Neurogastroenterol Motil. 2018;30(6):e13302.
  • Simkó J, Csilek A, Karászi J, et al. Proarrhythmic potential of antimicrobial agents. Infection. 2008;36(3):194–206.
  • Itoh H, Crotti L, Aiba T, et al. The genetics underlying acquired long QT syndrome: impact for genetic screening. Eur Heart J. 2016;37(18) :1456–1464.
  • Benoit A, Bodiou C, Villain E, et al. QT long et arrêt circulatoire après une injection d'érythromycine chez un nouveau-né [QT prolongation and circulatory arrest after an injection of erythromycin in a newborn infant]. Arch Fr Pediatr. 1991;48(1):39–41.
  • Farrar HC, Walsh-Sukys MC, Kyllonen K, et al. Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the literature. Pediatr Infect Dis J. 1993;12(8):688–691.
  • Owens RC, Jr, Nolin TD. Antimicrobial-associated QT interval prolongation: pointes of interest. Clin Infect Dis. 2006;43(12):1603–1611.
  • Sarquella-Brugada G, Cesar S, Zambrano MD, et al. Electrocardiographic assessment and genetic analysis in neonates: a current topic of discussion. Curr Cardiol Rev. 2019;15(1):30–37.
  • Adler A, Novelli V, Amin AS, et al. An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome. Circulation. 2020;141(6):418–428.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.